Erica Kubly

Associate
Get in touch

Erica is a litigation associate at Seeger Weiss. Her practice focuses primarily on mass tort litigation involving pharmaceutical injury.

  • Practice Areas: Drug Injury, Defective Products, Class Action Claims, Whistleblower Claims, Catastrophic Injury, Toxic Exposure, Personal Injury
  • Email: ekubly@seegerweiss.com
  • Call: 212-584-0700

Erica Kubly


Erica is a litigation associate at Seeger Weiss. Her practice focuses primarily on mass tort litigation involving pharmaceutical injury.

Bar Admissions

  • New York
  • Illinois

SELECTED REPRESENTATION

  • Member of the Seeger Weiss trial team appointed Lead Trial Counsel in representing Tennessee plaintiff as part of a multidistrict litigation against pharmaceutical giant AbbVie, for fraudulently marketing testosterone drug AndroGel; the plaintiff was awarded $140 million in punitive damages by a federal jury in Chicago. Involvement included preparing regulatory expert for testimony as well as assisting in the preparation for cross examination of a corporate witness.
  • Member of the trial team appointed Co-Lead Counsel in representing Oregon plaintiff as part of the MDL against AbbVie; the plaintiff was awarded $150 million in punitive damages by a federal jury in Chicago. Involvement included preparing regulatory expert for testimony as well as assisting in the preparation for cross-examination of a corporate witness.
  • Member of trial team appointed to the Plaintiffs’ Executive Committee in an MDL against Fresenius Medical Care Holdings, alleging defective design and failure to warn concerning its dry acid concentrate products, Granuflo and Naturalyte, which were subject to a Class I recall by the FDA. Involvement included discovery and assisting in preparation of corporate witnesses. The case resulted in a $250 million settlement agreement.
  • Member of the trial team representing plaintiffs in MDL against Depuy Orthopedics, a subsidiary of Johnson & Johnson, on claims concerning defective design, failure to warn and unfair and deceptive trade practices concerning their ASR hip implant product. Involvement included discovery and assisting in preparation of corporate witness depositions.

FREE CASE EVALUATION

Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.